Testing effectiveness (Phase 2)UnknownNCT06114329
What this trial is testing
Study of the Safety and Biologic Activity of AL01211 in Treatment Naive Males With Classic Fabry Disease
Who this might be right for
Fabry Disease
AceLink Therapeutics, Inc. 16